SNES

+ Watchlist + Portfolio

SenesTech, Inc.

Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.67
52-Week Range: $0.63 – $4.45
Market Cap: $4.22M
P/E (TTM): —
EPS (TTM): -1.22
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 0.68
PEG Ratio: —
Return on Equity: -107.41%
Return on Assets: -45.55%
Gross Margin: 66.17%
Operating Margin: -241.82%
Profit Margin: -294.73%
Current Ratio: 6.78
Debt/Equity: 0.43
Total Debt: $2.58M
Free Cash Flow: $-4.36M
Revenue Growth: 23.20%
Earnings Growth: —
Enterprise Value: $1.72M

SNES Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$1.02M	$1.19M	$1.86M	$2.22M
Cost of Revenue	$555.00K	$654.00K	$853.00K	$833.00K
Gross Profit	$464.00K	$539.00K	$1.00M	$1.39M
Research & Development	$1.86M	$1.23M	$1.71M	$1.70M
Selling, General & Admin	$8.22M	$7.04M	$5.54M	$6.20M
Operating Expenses	$10.14M	$8.27M	$7.25M	$7.89M
Operating Income	-$9.67M	-$7.73M	-$6.25M	-$6.50M
EBITDA	-$9.51M	-$7.57M	-$6.01M	-$6.23M
Pretax Income	-$9.70M	-$7.71M	-$6.18M	-$6.38M
Net Income	-$9.70M	-$7.71M	-$6.18M	-$6.38M
Diluted EPS	-1860.00	-115.10	-8.86	-1.95
Diluted Shares	5211	66986	697974	3.28M

SNES Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$4.78M	$5.39M	$1.31M	$7.58M
Receivables	$113.00K	$95.00K	$335.00K	$201.00K
Inventory	$853.00K	$795.00K	$794.00K	$994.00K
Current Assets	$6.12M	$6.67M	$2.81M	$10.06M
Total Assets	$6.78M	$7.29M	$3.28M	$12.84M
Current Liabilities	$1.32M	$786.00K	$561.00K	$798.00K
Long-Term Debt	—	$156.00K	$206.00K	$145.00K
Total Debt	$359.00K	$406.00K	$262.00K	$2.68M
Total Liabilities	$1.50M	$942.00K	$767.00K	$3.27M
Retained Earnings	-$122.20M	-$129.91M	-$136.10M	-$142.48M
Shareholders' Equity	$5.28M	$6.35M	$2.51M	$9.57M
Working Capital	$4.79M	$5.89M	$2.25M	$9.26M

SNES Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$8.58M	-$7.57M	-$6.03M	-$5.75M
Capital Expenditure	-$174.00K	-$149.00K	-$84.00K	-$138.00K
Free Cash Flow	-$8.75M	-$7.71M	-$6.12M	-$5.89M
Depreciation & Amortisation	$183.00K	$135.00K	$156.00K	$135.00K
Stock-Based Compensation	$711.00K	$555.00K	$326.00K	$264.00K
Investing Cash Flow	-$170.00K	-$149.00K	-$56.00K	-$1.10M
Financing Cash Flow	$4.20M	$8.34M	$2.00M	$13.12M
Net Change in Cash	-$4.55M	$620.00K	-$4.09M	$6.27M

SNES Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$485.00K	$625.00K	$690.00K	$421.00K	$493.00K	$770.00K
Cost of Revenue	$172.00K	$216.00K	$257.00K	$188.00K	$155.00K	$203.00K
Gross Profit	$313.00K	$409.00K	$433.00K	$233.00K	$338.00K	$567.00K
Research & Development	$418.00K	$427.00K	$400.00K	$453.00K	$422.00K	$377.00K
Selling, General & Admin	$1.56M	$1.60M	$1.38M	$1.66M	$2.04M	$2.05M
Operating Expenses	$1.98M	$2.02M	$1.78M	$2.11M	$2.46M	$2.43M
Operating Income	-$1.66M	-$1.61M	-$1.35M	-$1.88M	-$2.12M	-$1.86M
EBITDA	-$1.62M	-$1.57M	-$1.26M	-$1.77M	-$2.03M	-$1.80M
Pretax Income	-$1.67M	-$1.62M	-$1.30M	-$1.80M	-$2.06M	-$1.83M
Net Income	-$1.67M	-$1.62M	-$1.30M	-$1.80M	-$2.06M	-$1.83M
Diluted EPS	-1.28	-0.87	-0.28	-0.35	-0.39	-0.35
Diluted Shares	1.30M	1.85M	4.67M	5.22M	5.26M	5.30M

SNES Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$1.66M	$6.05M	$7.28M	$7.58M	$6.80M	$5.08M
Receivables	$498.00K	$470.00K	$454.00K	$201.00K	$163.00K	$361.00K
Inventory	$753.00K	$729.00K	$825.00K	$994.00K	$1.05M	$969.00K
Current Assets	$3.16M	$7.47M	$11.78M	$10.06M	$8.35M	$6.78M
Total Assets	$3.63M	$10.37M	$14.62M	$12.84M	$11.06M	$9.42M
Current Liabilities	$543.00K	$810.00K	$748.00K	$798.00K	$938.00K	$1.00M
Long-Term Debt	$191.00K	$175.00K	$160.00K	$145.00K	$128.00K	$111.00K
Total Debt	$248.00K	$2.69M	$2.68M	$2.68M	$2.63M	$2.58M
Total Liabilities	$734.00K	$3.39M	$3.28M	$3.27M	$3.36M	$3.37M
Retained Earnings	-$137.76M	-$139.38M	-$140.68M	-$142.48M	-$144.54M	-$146.38M
Shareholders' Equity	$2.89M	$6.98M	$11.35M	$9.57M	$7.70M	$6.05M
Working Capital	$2.62M	$6.66M	$11.03M	$9.26M	$7.42M	$5.78M

SNES Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$1.56M	-$1.15M	-$1.38M	-$1.66M	-$1.93M	-$1.71M
Capital Expenditure	-$36.00K	-$47.00K	-$42.00K	-$13.00K	—	—
Free Cash Flow	-$1.59M	-$1.20M	-$1.42M	-$1.68M	-$1.93M	-$1.71M
Depreciation & Amortisation	$39.00K	$35.00K	$29.00K	$32.00K	$31.00K	$31.00K
Stock-Based Compensation	$91.00K	$90.00K	$47.00K	$36.00K	$23.00K	$182.00K
Investing Cash Flow	-$36.00K	-$47.00K	-$3.01M	$1.99M	$1.00M	$0.00
Financing Cash Flow	$1.94M	$5.60M	$5.61M	-$26.00K	$158.00K	-$15.00K
Net Change in Cash	$348.00K	$4.40M	$1.22M	$297.00K	-$771.00K	-$1.72M

Market Snapshot

About

SenesTech is a biotechnology company focused on developing and commercializing innovative pest management solutions. The company offers ContraPest, a non-lethal fertility control technology designed to manage rat populations through reducing reproduction. SenesTech provides an alternative approach to traditional pest control methods.